NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tailor Bio

Tailor Bio

Private
CambridgeHealthcare & Life Scienceshttps://www.tailor.bio/

Last Round

Seed

Feb 7, 2023

Total Funding Raised

$5.89M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Tailor Bio is a biotechnology company that operates an AI-driven drug discovery platform for pan-cancer precision medicine, focusing on identifying chromosomal instability (CIN) signatures to predict patient response to cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

precision medicinechromosomal instabilityCINcompanion diagnosticstechbiooncology drug discoverypatient stratificationgenomic testingtargeted cancer therapyai drug discoverybiomarker discoverycomputational biologyai oncologydrug development platformcancer research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tailor Bio Comparables

Compare Tailor Bio with similar companies based on industry and business-model similarity.

Tailor Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tessellate BIO
74%
Volastra Therapeutics
73%
Roche Holding
70%

Tailor Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 7, 2023
SeedNov 30, 2022
GrantJul 11, 2022
GrantJun 29, 2020
AcceleratorJun 22, 2020

Tailor Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 1069% MoM, reaching 1.1K.

  • Nov 30, 2022

    $2.5M round with Acequia Capital and First In Ventures.

Tailor Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tailor Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tailor Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range20
Year Founded2019
Last FundingFeb 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.